Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Investigational New Drugs|June 9, 1999
Cryptophycin 1 cellular levels and effects in vitro using L1210 cellsB J Foster, M Fortuna, J Media, et al.Investigational New Drugs|August 1, 1990
Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of miceP Mucci-LoRusso, L Polin, L A Biernat, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Detoxification ability and toxicity of quinones in mouse and human tumor cell lines used for anticancer drug screeningZ Djuric, T H Corbett, F A Valeriote, et al.Journal of the National Cancer Institute|June 5, 1991
Effects of a low-fat diet on levels of oxidative damage to DNA to human peripheral nucleated blood cellsZ Djuric, L K Heilbrun, B A Reading, et al.Cancer Research|March 1, 1988
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivoM C Bissery, F A Valeriote, G G Chabot, et al.Oncology Research|October 21, 1998
Anticancer activity of glaucarubinone analoguesF A Valeriote, T H Corbett, P A Grieco, et al.Phytochemistry Letters|February 28, 2012
Unraveling the Numerous Biosynthetic Products of the Marine Sediment-Derived Fungus, Aspergillus insulicolaQ X Wu, X J Jin, M Draskovic, et al.Investigational New Drugs|January 1, 1990
A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group studyM B Edelstein, J J Crowley, F A Valeriote, et al.Journal of Natural Products|September 28, 1998
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.Journal of Natural Products|October 24, 1998
Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblagesG G Harrigan, W Y Yoshida, R E Moore, et al.Pageof 3